CymitQuimica logo

ATRA-BA Hybrid

CAS:

Ref. TM-T35629

ATRA-BA Hybrid
Targetmol

Product Information

Name:ATRA-BA Hybrid
Brand:Targetmol
Description:ATRA-BA, a prodrug, releases ATRA and butyric acid to inhibit MDA-MB-231 and PC3 cancer cells with enhanced potency at 20 μM.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:476.65
Formula:C31H40O4
Color/Form:Solid

Technical inquiry about: ATRA-BA Hybrid

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.